Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Necroptosis and tumor progression.

Literature DB >> 34627742

Necroptosis and tumor progression.

Jiong Yan¹, Peixing Wan¹, Swati Choksi¹, Zheng-Gang Liu².

Abstract

Necroptosis, a form of programmed necrotic cell death, is a gatekeeper of host defense against certain pathogen invasions. The deregulation of necroptosis is also a key factor of many inflammatory diseases. Recent studies have revealed an important role of necroptosis in tumorigenesis and metastasis and imply the potential of targeting necroptosis as a novel cancer therapy. While its molecular mechanism has been well studied, details of the regulation and function of necroptosis of tumor cells in tumorigenesis and metastasis only began to emerge recently, and we discuss these herein. Published by Elsevier Inc.

Entities: Chemical

Keywords: MLKL; RIPK3; ZBP1; antitumor immunity; metastasis; necroptosis; tumorigenesis

Mesh：

Substances：

Year: 2021 PMID： 34627742 PMCID： PMC8702466 DOI： 10.1016/j.trecan.2021.09.003

Source DB: PubMed Journal: Trends Cancer ISSN： 2405-8025

51 in total

1. Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity.

Authors: Tania Løve Aaes; Agnieszka Kaczmarek; Tinneke Delvaeye; Bram De Craene; Stefaan De Koker; Liesbeth Heyndrickx; Iris Delrue; Joachim Taminau; Bartosz Wiernicki; Philippe De Groote; Abhishek D Garg; Luc Leybaert; Johan Grooten; Mathieu J M Bertrand; Patrizia Agostinis; Geert Berx; Wim Declercq; Peter Vandenabeele; Dmitri V Krysko
Journal: Cell Rep Date: 2016-03-31 Impact factor: 9.423

2. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.

Authors: Jason W Upton; William J Kaiser; Edward S Mocarski
Journal: Cell Host Microbe Date: 2012-03-15 Impact factor: 21.023

3. RIPK1 inhibits ZBP1-driven necroptosis during development.

Authors: Kim Newton; Katherine E Wickliffe; Allie Maltzman; Debra L Dugger; Andreas Strasser; Victoria C Pham; Jennie R Lill; Merone Roose-Girma; Søren Warming; Margaret Solon; Hai Ngu; Joshua D Webster; Vishva M Dixit
Journal: Nature Date: 2016-11-07 Impact factor: 49.962

Review 4. Necroptosis and Inflammation.

Authors: Kim Newton; Gerard Manning
Journal: Annu Rev Biochem Date: 2016-02-08 Impact factor: 23.643

5. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors: M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal: Immunity Date: 1998-03 Impact factor: 31.745

6. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

Authors: Sudan He; Lai Wang; Lin Miao; Tao Wang; Fenghe Du; Liping Zhao; Xiaodong Wang
Journal: Cell Date: 2009-06-12 Impact factor: 41.582

7. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer.

Authors: Wei Wang; Jill M Marinis; Allison M Beal; Shivraj Savadkar; Yue Wu; Mohammed Khan; Pardeep S Taunk; Nan Wu; Wenyu Su; Jingjing Wu; Aarif Ahsan; Emma Kurz; Ting Chen; Inedouye Yaboh; Fei Li; Johana Gutierrez; Brian Diskin; Mautin Hundeyin; Michael Reilly; John D Lich; Philip A Harris; Mukesh K Mahajan; James H Thorpe; Pamela Nassau; Julie E Mosley; Joshua Leinwand; Juan A Kochen Rossi; Ankita Mishra; Berk Aykut; Michael Glacken; Atsuo Ochi; Narendra Verma; Jacqueline I Kim; Varshini Vasudevaraja; Dennis Adeegbe; Christina Almonte; Ece Bagdatlioglu; Deirdre J Cohen; Kwok-Kin Wong; John Bertin; George Miller
Journal: Cancer Cell Date: 2018-11-12 Impact factor: 31.743

8. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.

Authors: Juan Lin; Snehlata Kumari; Chun Kim; Trieu-My Van; Laurens Wachsmuth; Apostolos Polykratis; Manolis Pasparakis
Journal: Nature Date: 2016-11-07 Impact factor: 49.962

9. Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells.

Authors: Rachel Thijssen; Silvia Alvarez-Diaz; Clea Grace; Ming-Yuan Gao; David H Segal; Zhen Xu; Andreas Strasser; David C S Huang
Journal: Cell Death Differ Date: 2020-06-18 Impact factor: 15.828

10. BRAF and AXL oncogenes drive RIPK3 expression loss in cancer.

Authors: Ayaz Najafov; Ioannis K Zervantonakis; Adnan K Mookhtiar; Patricia Greninger; Ryan J March; Regina K Egan; Hoang Son Luu; Daniel G Stover; Ursula A Matulonis; Cyril H Benes; Junying Yuan
Journal: PLoS Biol Date: 2018-08-29 Impact factor: 8.029

35 in total

1. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.

Authors: Qikai Zhang; Zongsi Zhu; Jiaqiang Guan; Cuiping Zheng
Journal: Front Oncol Date: 2022-06-22 Impact factor: 5.738

2. Necroptosis-associated classification combined with tumor microenvironment characteristic analysis of cutaneous melanoma.

Authors: Gang Hu; Yan Jiang; Jianying Ma; Hui Zhan
Journal: Sci Rep Date: 2022-05-24 Impact factor: 4.996

3. Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer.

Authors: Cheng Ding; ZhangPing Yu; JiQiao Zhu; XianLiang Li; MengHua Dai
Journal: Dis Markers Date: 2022-06-14 Impact factor: 3.464

4. Knowledge Mapping of Necroptosis From 2012 to 2021: A Bibliometric Analysis.

Authors: Jie Zhang; Luxia Song; Jundi Jia; Wende Tian; Runmin Lai; Zihao Zhang; Jingen Li; Jianqing Ju; Hao Xu
Journal: Front Immunol Date: 2022-06-13 Impact factor: 8.786

5. Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer.

Authors: Li Liu; Liu Huang; Wenzheng Chen; Guoyang Zhang; Yebei Li; Yukang Wu; Jianbo Xiong; Zhigang Jie
Journal: Front Mol Biosci Date: 2022-02-14

10. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.

Authors: Juntao Huang; Ziqian Xu; Bing Mei Teh; Chongchang Zhou; Zhechen Yuan; Yunbin Shi; Yi Shen
Journal: J Clin Lab Anal Date: 2022-05-06 Impact factor: 3.124